GSK plc

LSE:GSK Stock Report

Market Cap: UK£53.0b

GSK Management

Management criteria checks 2/4

GSK's CEO is Emma Walmsley, appointed in Apr 2017, has a tenure of 7.58 years. total yearly compensation is £12.72M, comprised of 10.3% salary and 89.7% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth £21.17M. The average tenure of the management team and the board of directors is 6 years and 3.2 years respectively.

Key information

Emma Walmsley

Chief executive officer

UK£12.7m

Total compensation

CEO salary percentage10.3%
CEO tenure7.6yrs
CEO ownership0.04%
Management average tenure6yrs
Board average tenure3.2yrs

Recent management updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

May 02
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

Recent updates

GSK's (LON:GSK) Conservative Accounting Might Explain Soft Earnings

Nov 06
GSK's (LON:GSK) Conservative Accounting Might Explain Soft Earnings

GSK plc (LON:GSK) Not Flying Under The Radar

Nov 02
GSK plc (LON:GSK) Not Flying Under The Radar

GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

Nov 02
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

Does GSK (LON:GSK) Have A Healthy Balance Sheet?

Sep 01
Does GSK (LON:GSK) Have A Healthy Balance Sheet?

GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

Aug 05
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

GSK (LON:GSK) Will Pay A Dividend Of £0.15

May 05
GSK (LON:GSK) Will Pay A Dividend Of £0.15

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

May 02
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

These 4 Measures Indicate That GSK (LON:GSK) Is Using Debt Reasonably Well

Apr 19
These 4 Measures Indicate That GSK (LON:GSK) Is Using Debt Reasonably Well

CEO Compensation Analysis

How has Emma Walmsley's remuneration changed compared to GSK's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

UK£3b

Jun 30 2024n/an/a

UK£4b

Mar 31 2024n/an/a

UK£4b

Dec 31 2023UK£13mUK£1m

UK£5b

Sep 30 2023n/an/a

UK£6b

Jun 30 2023n/an/a

UK£5b

Mar 31 2023n/an/a

UK£4b

Dec 31 2022UK£8mUK£1m

UK£4b

Sep 30 2022n/an/a

UK£3b

Jun 30 2022n/an/a

UK£4b

Mar 31 2022n/an/a

UK£4b

Dec 31 2021UK£8mUK£1m

UK£3b

Sep 30 2021n/an/a

UK£4b

Jun 30 2021n/an/a

UK£4b

Mar 31 2021n/an/a

UK£5b

Dec 31 2020UK£7mUK£1m

UK£5b

Sep 30 2020n/an/a

UK£6b

Jun 30 2020n/an/a

UK£7b

Mar 31 2020n/an/a

UK£5b

Dec 31 2019UK£8mUK£1m

UK£5b

Sep 30 2019n/an/a

UK£5b

Jun 30 2019n/an/a

UK£4b

Mar 31 2019n/an/a

UK£4b

Dec 31 2018UK£6mUK£1m

UK£4b

Sep 30 2018n/an/a

UK£2b

Jun 30 2018n/an/a

UK£2b

Mar 31 2018n/an/a

UK£1b

Dec 31 2017UK£5mUK£965k

UK£2b

Compensation vs Market: Emma's total compensation ($USD16.08M) is above average for companies of similar size in the UK market ($USD5.72M).

Compensation vs Earnings: Emma's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Emma Walmsley (55 yo)

7.6yrs

Tenure

UK£12,718,000

Compensation

Dame Emma N. Walmsley serves as an Independent Director of Microsoft Corp. since December 4, 2019. She serves as Chief Executive Officer of GlaxoSmithKline Plc since April 1, 2017. Dame Walmsley served as...

Leadership Team

NamePositionTenureCompensationOwnership
Emma Walmsley
CEO & Director7.6yrsUK£12.72m0.040%
£ 21.2m
Julie Brown
CFO & Executive Director1.6yrsUK£5.14m0.0024%
£ 1.3m
Shobie Ramakrishnan
Chief Digital & Technology Officer3.8yrsno datano data
Tony Wood
Chief Scientific Officer and Head of R&D2.3yrsno datano data
Sarah Elton-Farr
Head of Investor Relationsno datano datano data
James Ford
Senior VP & Group General Counsel of Legal & Compliance6.3yrsno datano data
Sally Jackson
Senior Vice President of Global Communications & CEO Office5.7yrsno datano data
David Redfern
President of Corporate Developmentno datano datano data
Diana Conrad
Chief People Officer5.6yrsno datano data
Philip Thomson
President of Global Affairs7.6yrsno data0.0057%
£ 3.0m
Luke Miels
Chief Commercial Officer7.2yrsno datano data
Kevin Sin
Senior VP & Head of Worldwide Business Development for Pharmaceuticals Research Development6.4yrsno datano data

6.0yrs

Average Tenure

55yo

Average Age

Experienced Management: GSK's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Emma Walmsley
CEO & Director7.8yrsUK£12.72m0.040%
£ 21.2m
Julie Brown
CFO & Executive Director1.5yrsUK£5.14m0.0024%
£ 1.3m
Jonathan Symonds
Non-Executive Chairman5.2yrsUK£765.00k0.0020%
£ 1.0m
Vishal Sikka
Independent Non-Executive Director2.3yrsUK£147.00k0.00036%
£ 191.0k
Hal Barron
Non-Executive Director6.8yrsUK£356.92k0.032%
£ 17.0m
Harry Dietz
Independent Non-Executive Director2.8yrsUK£207.09k0.00016%
£ 84.9k
Anne Beal
Independent Non-Executive Director3.5yrsUK£174.93k0.00017%
£ 90.2k
Wendy Mira Becker
Independent Non-Executive Director1.1yrsUK£32.00k0.000040%
£ 21.2k
Charles Bancroft
Senior Independent Non-Executive Director4.5yrsUK£323.00k0.0014%
£ 758.6k
Tsun-Huei Lee
Independent Non-Executive Directorless than a yearno data0.000030%
£ 15.9k
Elizabeth Anderson
Independent Non-Executive Director2.2yrsUK£127.86k0.000090%
£ 47.7k
Jesse Goodman
Independent Non-Executive Director8.8yrsUK£173.36k0.00073%
£ 387.2k

3.2yrs

Average Tenure

62yo

Average Age

Experienced Board: GSK's board of directors are considered experienced (3.2 years average tenure).